Skip to main content
. 2021 Jun 15;1(1):53–64. doi: 10.1016/j.jacasi.2021.04.002

Table 4.

Unadjusted Clinical Outcomes According to an Additional SB-Opening Procedure for LM or True Bifurcation Lesions

Event Rates at 5-year
Unadjusted
IPTW Adjusted
Simple Crossover SB Opening HR (95% CI) p Value HR (95% CI) p Value
LM lesion 489 193
 Target lesion failure 37 (9.5) 19 (11.3) 1.24 (0.72–2.14) 0.442 0.92 (0.41–2.06) 0.836
 Death from any cause 33 (8.2) 7 (4.1) 0.49 (0.22–1.11) 0.086 0.83 (0.27–2.56) 0.741
 Cardiac 20 (5.1) 5 (3.0) 0.60 (0.23–1.59) 0.303 0.79 (0.19–3.36) 0.755
 Noncardiac 12 (3.1) 2 (1.1) 0.33 (0.08–1.46) 0.145 0.84 (0.13–5.41) 0.854
 MI 8 (1.9) 8 (4.7) 2.27 (0.88–5.88) 0.092 3.62 (1.05–12.44) 0.041
 Target-vessel MI 6 (1.4) 5 (3.0) 1.82 (0.58–5.74) 0.306 2.44 (0.51–11.56) 0.261
 Any revascularization 43 (11.2) 25 (15.0) 1.50 (0.93–2.43) 0.100 1.50 (0.73–3.09) 0.271
 Target lesion 18 (4.8) 12 (7.3) 1.53 (0.75–3.14) 0.241 1.34 (0.47–3.81) 0.580
 Target vessel 27 (7.1) 20 (11.9) 1.87 (1.07–3.28) 0.029 1.30 (0.59–2.89) 0.519
 Definite stent thrombosis 7 (1.6) 0 (0) 0.32 (0.04–2.56) 0.282 1.44 (0.24–8.7) 0.692
True bifurcation 1,196 316
 Target-lesion failure 26 (5.3) 19 (7.8) 1.29 (0.74–2.26) 0.362 0.93 (0.43–2.01) 0.854
 Death from any cause 29 (5.8) 11 (4.4) 0.74 (0.38–1.43) 0.372 0.68 (0.27–1.76) 0.432
 Cardiac 16 (3.1) 9 (3.7) 1.07 (0.5–2.29) 0.856 1.10 (0.39–3.11) 0.864
 Noncardiac 13 (2.8) 2 (0.8) 0.29 (0.07–1.28) 0.103 0.13 (0.03–0.57) 0.007
 MI 6 (1.3) 4 (1.5) 1.06 (0.32–3.53) 0.921 0.46 (0.14–1.56) 0.214
 Target vessel MI 3 (0.5) 3 (1.2) 1.56 (0.35–6.99) 0.559 0.64 (0.14–2.88) 0.561
 Any revascularization 41 (8.2) 23 (9.4) 0.98 (0.6–1.6) 0.928 0.63 (0.3–1.3) 0.210
 Target lesion 11 (2.4) 8 (3.4) 1.24 (0.52–2.97) 0.622 0.55 (0.22–1.33) 0.181
 Target vessel 23 (4.8) 15 (6.3) 1.17 (0.62–2.19) 0.632 0.58 (0.28–1.19) 0.140
 Definite stent thrombosis 4 (0.7) 2 (0.8) 1.28 (0.3–5.35) 0.739 2.09 (0.37–11.85) 0.405

Values are n or n (%), unless noted otherwise.

Abbreviations as in Figures 1 and 3.

Event rates are based on Kaplan-Meier estimates.

Hazard ratios are for the SB-opening group compared to the simple crossover group.

Target lesion failure was defined as a composite of death by cardiac causes, target vessel MI, or target lesion revascularization.